368 related articles for article (PubMed ID: 24341564)
1. Characteristics of agranulocytosis as an adverse effect of antithyroid drugs in the second or later course of treatment.
Kobayashi S; Noh JY; Mukasa K; Kunii Y; Watanabe N; Matsumoto M; Ohye H; Suzuki M; Yoshihara A; Iwaku K; Sugino K; Ito K
Thyroid; 2014 May; 24(5):796-801. PubMed ID: 24341564
[TBL] [Abstract][Full Text] [Related]
2. Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan.
Nakamura H; Miyauchi A; Miyawaki N; Imagawa J
J Clin Endocrinol Metab; 2013 Dec; 98(12):4776-83. PubMed ID: 24057289
[TBL] [Abstract][Full Text] [Related]
3. Antithyroid drug-induced hematopoietic damage: a retrospective cohort study of agranulocytosis and pancytopenia involving 50,385 patients with Graves' disease.
Watanabe N; Narimatsu H; Noh JY; Yamaguchi T; Kobayashi K; Kami M; Kunii Y; Mukasa K; Ito K; Ito K
J Clin Endocrinol Metab; 2012 Jan; 97(1):E49-53. PubMed ID: 22049174
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of Antithyroid Drug-Induced Agranulocytosis in Patients with Hyperthyroidism: A Retrospective Analysis of 114 Cases in a Single Institution in China Involving 9690 Patients Referred for Radioiodine Treatment Over 15 Years.
Yang J; Zhu YJ; Zhong JJ; Zhang J; Weng WW; Liu ZF; Xu Q; Dong MJ
Thyroid; 2016 May; 26(5):627-33. PubMed ID: 26867063
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of 18 cases of antithyroid drug (ATD)-induced agranulocytosis.
Dai WX; Zhang JD; Zhan SW; Xu BZ; Jin H; Yao Y; Xin WC; Bai Y
Endocr J; 2002 Feb; 49(1):29-33. PubMed ID: 12008747
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of granulocyte count measurement four hours after injection of granulocyte colony-stimulating factor for detecting recovery from antithyroid drug-induced granulocytopenia.
Tajiri J; Noguchi S; Murakami N
Thyroid; 1997 Aug; 7(4):575-8. PubMed ID: 9292945
[TBL] [Abstract][Full Text] [Related]
7. [Retrospective analysis of 18 cases with agranulocytosis induced by antithyroid drugs].
Dai W; Zhang J; Zhan Z; Xu B; Jin H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Jun; 20(3):226-9. PubMed ID: 11367711
[TBL] [Abstract][Full Text] [Related]
8. [The occurrence of agranulocytosis due to antithyroid drugs in a cohort of patients with Graves disease treated with radioactive iodine 131I during 14 years].
Cepková J; Gabalec F; Svilias I; Horáček J
Vnitr Lek; 2014 Oct; 60(10):832-6. PubMed ID: 25382005
[TBL] [Abstract][Full Text] [Related]
9. Hepatotoxicity and cutaneous reactions after antithyroid drug administration.
Otsuka F; Noh JY; Chino T; Shimizu T; Mukasa K; Ito K; Ito K; Taniyama M
Clin Endocrinol (Oxf); 2012 Aug; 77(2):310-5. PubMed ID: 22332800
[TBL] [Abstract][Full Text] [Related]
10. Antithyroid drug treatment for graves' disease in children: a long-term retrospective study at a single institution.
Ohye H; Minagawa A; Noh JY; Mukasa K; Kunii Y; Watanabe N; Matsumoto M; Suzuki M; Yoshihara A; Ito K; Ito K
Thyroid; 2014 Feb; 24(2):200-7. PubMed ID: 23926918
[TBL] [Abstract][Full Text] [Related]
11. Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily.
Takata K; Kubota S; Fukata S; Kudo T; Nishihara E; Ito M; Amino N; Miyauchi A
Thyroid; 2009 Jun; 19(6):559-63. PubMed ID: 19445623
[TBL] [Abstract][Full Text] [Related]
12. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis.
Wall JR; Fang SL; Kuroki T; Ingbar SH; Braverman LE
J Clin Endocrinol Metab; 1984 May; 58(5):868-72. PubMed ID: 6200492
[TBL] [Abstract][Full Text] [Related]
13. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
[TBL] [Abstract][Full Text] [Related]
14. Analysis of 90 cases of antithyroid drug-induced severe hepatotoxicity over 13 years in China.
Yang J; Li LF; Xu Q; Zhang J; Weng WW; Zhu YJ; Dong MJ
Thyroid; 2015 Mar; 25(3):278-83. PubMed ID: 25384184
[TBL] [Abstract][Full Text] [Related]
15. The relationship between bone marrow characteristics and the clinical prognosis of antithyroid drug-induced agranulocytosis.
Yang J; Zhong J; Xiao XH; Zhou LZ; Chen YJ; Liu JH; Cao RX; Wen GB
Endocr J; 2013; 60(2):185-9. PubMed ID: 23117149
[TBL] [Abstract][Full Text] [Related]
16. Propylthiouracil (PTU)-induced agranulocytosis treated with recombinant human granulocyte colony-stimulating factor (G-CSF).
Balkin MS; Buchholtz M; Ortiz J; Green AJ
Thyroid; 1993; 3(4):305-9. PubMed ID: 7509672
[TBL] [Abstract][Full Text] [Related]
17. Thionamide-induced Agranulocytosis: A Retrospective Analysis of 36 Patients With Hyperthyroidism.
Zhu D; Zhang S; Cao X; Xia Q; Zhang Q; Deng D; Gao S; Yu H; Liu Y; Zhou H; Tao F; Sun X
Endocr Pract; 2021 Dec; 27(12):1183-1188. PubMed ID: 34216800
[TBL] [Abstract][Full Text] [Related]
18. Antithyroid drug-induced agranulocytosis: special reference to normal white blood cell count agranulocytosis.
Tajiri J; Noguchi S
Thyroid; 2004 Jun; 14(6):459-62. PubMed ID: 15242574
[TBL] [Abstract][Full Text] [Related]
19. Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring.
Tajiri J; Noguchi S; Murakami T; Murakami N
Arch Intern Med; 1990 Mar; 150(3):621-4. PubMed ID: 2310281
[TBL] [Abstract][Full Text] [Related]
20. Immunological: reactions involving leukocytes: III. Agranulocytosis induced by antithyroid drugs.
Bilezikian SB; Laleli Y; Tsan MF; Hodkinson BA; Ice S; McIntyre PA
Johns Hopkins Med J; 1976 Apr; 138(4):124-9. PubMed ID: 58084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
